Oncoxin®

DIETARY_SUPPLEMENT2 trials

Sponsors

Catalysis SL

Conditions

Gastric Cancer Stage IIGastric Cancer Stage IIIMucositis OralNon-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage III

Phase 2

Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

CompletedNCT03577535

Catalysis SLMucositis Oral

Start: 2017-11-01End: 2018-07-15Updated: 2018-08-01

Phase 4

Oncoxin® and Quality of Life in Cancer Patients

CompletedNCT03550482

Catalysis SLGastric Cancer Stage II, Gastric Cancer Stage III, Non-small Cell Lung Cancer Stage II +1

Start: 2017-11-01End: 2019-05-15Updated: 2019-06-05

Related Papers

Multicomponent nutritional supplement Oncoxin and its influence on quality of life and therapy toxicity in patients receiving adjuvant chemotherapy

Oncology Letters2019-09-1311 citations